Home page > Article
|
Previous article
|
Next article
SEARCH
QUICKLINKS AND VIEW OPITONS
Phendimetrazine (Bontril): 70 mg three times per day most effect, but twice a day fewer side effects
Posted by .(JavaScript must be enabled to view this email address)
Friday, February 10, 2006 2:45 am Email this article
Studies report an average weight loss as much as 15 percent with 70 mg of phendimetrazine three times per day, however, considering side effects, the optimum dose may be 70 mg twice a day. REFERENCES
Beckett AH; Raisi A. Bioavailability in man of phendimetrazine from various dosage forms [proceedings]. Journal of Pharmacy and Pharmacology, 1976 Dec, 28 Suppl:40P.
Cass LJ. Evaluation of phendimetrazine bitartrate as an appetite suppressant. Canadian Medical Association Journal, 1961 May 20;84:1114-6.
Cui JF; Zhou Y; Cui KR; Li L; Zhou TH. [Study on metabolism of phenmetrazine-like drugs and their metabolites]. Yao Hsueh Hsueh Pao Acta Pharmaceutica Sinica, 1990, 25(8):632-6.
Holmes JH; Sapeika N; Zwarenstein H. Effect of anti-obesity drugs on lipase activity in vitro. Research Communications in Chemical Pathology and Pharmacology, 1975 Apr, 10(4):739-42.
Hood I; Monforte J; Gault R; Mirchandani H. Fatality from illicit phendimetrazine use. Journal of Toxicology. Clinical Toxicology, 1988, 26(3-4):249-55.
Kokkinos J; Levine SR. Possible association of ischemic stroke with phentermine. Stroke, 1993 Feb, 24(2):310-3.
Le Riche WH; Van Belle G. Study of phendimetrazine bitartrate as an appetite suppressant in relation to dosage, weight loss and side effects. Canadian Medical Association Journal 1962 Jul 7;87:29-31.
Markowitz GS; Tartini A; D’Agati VD. Acute interstitial nephritis following treatment with anorectic agents phentermine and phendimetrazine. Clinical Nephrology, 1998 Oct, 50(4):252-4.
Mellar J; Hollister LE. Phenmetrazine: an obsolete problem drug. Clin Pharmacol Ther 1982 Dec;32(6):671-5.
Muller FO; Hundt HK; Gosling JA. Availability of phendimetrazine from sustained and non-sustained action formulations. South African Medical Journal, 1975 Feb 1, 49(5):135-9.
Nall KC, Rubin LJ, Lipskind S, Sennesh JD. Reversible pulmonary hypertension associated with anorexigen use [letter] [published erratum appears in Am J Med 1991 Dec,91(6):670]. American Journal of Medicine, 1991 Jul, 91(1):97-9.
Rostagno C; Caciolli S; Felici M; Gori F; Neri Serneri GG. Dilated cardiomyopathy associated with chronic consumption of phendimetrazine. American Heart Journal, 1996 Feb, 131(2):407-9.
Rudolph GR; Miksic JR; Levitt MJ. GLC determination of phendimetrazine in human plasma, serum, or urine. Journal of Pharmaceutical Sciences, 1983 May, 72(5):519-21.
Runyan JW Jr. Observations on the use of phendimetrazine, a new anorexigenic agent, in obese diabetics. Curr Ther Res 1962 May;4:270-5.
Young RE. Comparative study of phenmetrazine and phendimetrazine in the management of obesity. Curr Ther Res 1961 Aug;3(8):350-4.
Articles on the same subject can be found here:
COMMENTS
On Feb 13, 2006 at 3:34 am nynavae wrote:
. . . . .
Thank you for this review. The regular dosage for Bontril is 35mg x 3 a day though...seems the study used a bit more.
I am still curious about how it works compared to phentermine. Thanks again.
On Feb 13, 2006 at 3:57 am Larry Hobbs wrote:
. . . . .
Several studies were reviewed here.
Some of the studies were dosage studies trying to determine what dose worked best. That is why they tried higher doses.
70 mg three times per day caused the most weight loss, but also caused a number of side effects.
70 mg twice a day seemed to cause the most weight loss with fewer side effects.
Yes, you are right. The normal dose is 35 mg three times per day.
Phendimetrazine is a symptathomimetic drug, as is phentermine. The both work mainly via noradrenaline.
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.